BLTE — Belite Bio Inc

Ownership history in MPM BioImpact LLC  ·  1 quarter on record

This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Belite Bio Inc (BLTE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.61% (2025 Q4)
Avg. % of fund
1.61%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 87,760 — — 1.61% $14.0M $159.96
% of Fund (quarterly)    BLTE price (monthly, adj. close)

Other funds also holding BLTE

As of 2025 Q4 — sorted by position size

Darwin Global Management, Ltd. 3Y 9.86% Western Standard LLC 3Y 7Y 4.43% SUPERSTRING CAPITAL MANAGEMENT LP 2.12% PERCEPTIVE ADVISORS LLC 3Y 7Y 1.18% RTW INVESTMENTS, LP 3Y 7Y 1.15% Seven Fleet Capital Management LP 1.11% Exome Asset Management LLC 1.1% EVENTIDE ASSET MANAGEMENT, LLC 3Y 7Y 0.96% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.71% PSP Research LLC 0.48%
← Back to MPM BioImpact LLC Holdings